[25-012699] social determinants of obesity and cardiovascular risk laboratory requires antibodies for in order to the sleep study in menopausal women

Ended Purchase Order Awarded Last action

Contract number
75N92025P00293
Awardee
Awarding agency
Obligated
$23,679

Award facts

Contract value 100% obligated
$23,678.60 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
325413 In-Vitro Diagnostic Substance Manufacturing
PSC
6640 Laboratory Equipment And Supplies
Set-aside
No set-aside
Competition
Competed under SAP · 1 offer Simplified Acquisition
Pricing
Firm Fixed Price
Place of performance
San Jose, CA 95131, USA

Award details come from SAM.gov/FPDS.

About this award

The National Heart Lung and Blood Institute awarded a $23.7K purchase order to Becton, Dickinson and Company (BD), through its BDB Division operating as BD Biosciences, on August 1, 2025, for antibodies required to support a sleep study in menopausal women under the "Social Determinants of Obesity and Cardiovascular Risk Laboratory." This firm fixed-price contract, which will be completed by October 1, 2025, is being performed in San Jose, California. The contract was awarded without a set-aside designation to the large, established medical technology manufacturer, reflecting BD's competitive standing in federal procurement.

BD Biosciences specializes in flow cytometry, cell imaging, and genomics technologies, providing sophisticated reagents and laboratory equipment to federal agencies across multiple NIH components, the Department of Veterans Affairs, and other government entities. The antibodies procured under this purchase order will serve as critical research consumables for the National Heart Lung and Blood Institute's cardiovascular and obesity research initiatives, supporting investigations into how social determinants affect health outcomes in menopausal women.

Quick answers

Who was awarded contract 75N92025P00293?

75N92025P00293 was awarded to Becton, Dickinson And Company by National Heart Lung and Blood Institute (National Institutes of Health) on August 1, 2025.

How much is contract 75N92025P00293 worth?

The government has obligated $23,679 on 75N92025P00293.

Was contract 75N92025P00293 competed?

The extent of competition for 75N92025P00293 was competed under sap. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award